Biography
Dr Leone Oh is a Perth-trained medical oncologist who believes good cancer care begins with understanding the person behind the diagnosis. He takes time to understand each patient’s concerns, priorities and circumstances, clearly explaining diagnoses and treatment options so patients feel heard, supported and involved. His thorough, multidisciplinary approach incorporates current advances in oncology to support the best possible outcomes.
Biography
Dr Oh graduated from the University of Western Australia with a Bachelor of Medicine and Bachelor of Surgery in 2015. He completed specialist medical oncology training at Sir Charles Gairdner Hospital and Fiona Stanley Hospital, followed by a WA Cancer Research Fellowship in 2024. Alongside his work at Icon Cancer Centre, he is an adjunct senior lecturer at the University of Western Australia and a consultant medical oncologist at Rockingham General Hospital.
Dr Oh has a strong interest in medical education, clinical research and clinical trials. His research has been published in peer-reviewed journals and presented at national and international conferences. He is also a member of the national eviQ reference committee, which reviews cancer treatment protocols, and has contributed to clinical guidelines that support general practitioners caring for palliative patients in the community.
Recognising that every person may experience cancer differently, Dr Oh works closely with each patient and their broader care team. He aims to make complex information understandable and to help patients make informed decisions that reflect their goals, values and individual circumstances.
Publications
Leslie C, Al-Ogaili Z, Oh L, Slattery T, Shaji S, Marsavela G, Mills A, Stone C, Ferguson T. Lutetium-177-PSMA I&T (Lu-PSMA) with radiosensitising capecitabine in patients with metastatic castration-resistant prostate cancer (mCRPC): results of phase Ia study. Eur J Nucl Med Mol Imaging. 2026 Jun 19.
Keane KG, Hawks C, McCombie SP, Oh EL, Twycross M, Lim J, Redfern A, Hayne D. G-DISCO: Gemcitabine-Docetaxel Intravesical Synchronous CO-administration - a phase 1 study protocol. BJU Int. 2025 Oct 28.
Oh EL, Steinepreis E, Len C, Martin H. Metastatic Lobular Breast Cancer: Outcomes of Patients Treated at a Single Tertiary Institution. Asia Pac J Clin Oncol. 2025 Apr 29.
Oh EL, Huish W, El-Gamil S, Benson T, Ferguson T. Assessment of Patient and Clinician Perspectives on Clinically Meaningful Extension of Progression-free Survival in Prostate Cancer. European Urology Open Science. 2024;70:175-82.
Oh EL, Redfern A, Hayne D. An evaluation of durvalumab across the spectrum of urothelial carcinoma. Expert Rev Anticancer Ther. 2024 Nov;24(11):1101-1115